My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 889

    1.

    Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

    Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E; Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators.

    Ann Intern Med. 2007 Jun 5;146(11):761-7. Epub 2007 Apr 30.PMID: 17470822 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.

    Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E; Heart Outcomes Prevention Evaluation 2 Investigators.

    Stroke. 2009 Apr;40(4):1365-72. Epub 2009 Feb 19.PMID: 19228852 [PubMed - indexed for MEDLINE]Related articles

    3.

    Summaries for patients. Randomized trial of homocysteine-lowering therapy and risk for venous thromboembolism.

    [No authors listed]

    Ann Intern Med. 2007 Jun 5;146(11):I22. Epub 2007 Apr 30. No abstract available. PMID: 17470823 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

    den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM.

    Blood. 2007 Jan 1;109(1):139-44. Epub 2006 Sep 7.PMID: 16960155 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

    Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE.

    JAMA. 2008 May 7;299(17):2027-36.PMID: 18460663 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

    Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators.

    JAMA. 2007 Sep 12;298(10):1163-70. Erratum in: JAMA. 2008 Jul 9;300(2):170. PMID: 17848650 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

    Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M.

    JAMA. 2004 Feb 4;291(5):565-75.PMID: 14762035 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Homocysteine lowering with folic acid and B vitamins in vascular disease.

    Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.

    N Engl J Med. 2006 Apr 13;354(15):1567-77. Epub 2006 Mar 12. Erratum in: N Engl J Med. 2006 Aug 17;355(7):746. PMID: 16531613 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Homocysteine and venous thrombosis: outline of a vitamin intervention trial.

    Willems HP, den Heijer M, Bos GM.

    Semin Thromb Hemost. 2000;26(3):297-304.PMID: 11011847 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

    Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

    Can J Cardiol. 2006 Jan;22(1):47-53.PMID: 16450017 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.

    Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC.

    Clin Ther. 2007 Oct;29(10):2204-14.PMID: 18042476 [PubMed - indexed for MEDLINE]Related articles

    12.

    Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.

    Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O.

    JAMA. 2008 Aug 20;300(7):795-804.PMID: 18714059 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.

    Clarke R, Armitage J.

    Semin Thromb Hemost. 2000;26(3):341-8. Review.PMID: 11011852 [PubMed - indexed for MEDLINE]Related articles

    14.

    DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

    Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

    Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6. PMID: 14656016 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

    Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM.

    JAMA. 2002 Aug 28;288(8):973-9.PMID: 12190367 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Hyperhomocysteinemia as a risk factor for venous thrombosis]

    Willems HP, den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Bos GM.

    Ned Tijdschr Geneeskd. 1999 Mar 13;143(11):552-6. Review. Dutch. PMID: 10321272 [PubMed - indexed for MEDLINE]Related articles

    17.

    Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.

    Mann JF, Sheridan P, McQueen MJ, Held C, Arnold JM, Fodor G, Yusuf S, Lonn EM; HOPE-2 investigators.

    Nephrol Dial Transplant. 2008 Feb;23(2):645-53. Epub 2007 Nov 14.PMID: 18003666 [PubMed - indexed for MEDLINE]Related articles

    18.

    Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.

    Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.

    Stroke. 2006 Feb;37(2):456-60. Epub 2006 Jan 5.PMID: 16397167 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

    Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM.

    N Engl J Med. 2009 Apr 30;360(18):1851-61. Epub 2009 Mar 29.PMID: 19329822 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.

    Song Y, Cook NR, Albert CM, Van Denburgh M, Manson JE.

    Diabetes. 2009 Aug;58(8):1921-8. Epub 2009 Jun 2.PMID: 19491213 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity